MENU
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
United Therapeutics (UTHR) Ownership - Who owns United Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.24B
P/E Ratio
16.97
Total Cash
3.33B
Projected Growth
1.67
Total Debt
400M
Revenue
2.76B
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash/Share
74.51
Total Debt/Equity
21.97
Revenue/Share
56.39 USD as % of share price
Fundamentals
UTHR
Capitalization
17.2B
P/E Ratio
16.97
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash
3.33B
Total Cash/Share
74.51
Total Debt
400M
Total Debt/Equity
21.97
Projected Growth (PEG Ratio)
1.67
Revenue/Share (as % of the share price)
56.39%
Revenue
2.76B
ROE
N/A
Book Value
6.1B
P/B Ratio
2.83
Cash Flow
N/A
Earnings
24.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
700K
Current Ratio
4.58
Current Revenue Per Employee
641181.50
Dividends Per Share - Security
N/A
EBITDA
1.55B
Float
N/A
Float - Current
N/A
Gross Income Margin
88.90
Revenue To Assets
15.71
Shares Held By Institutions
37.1B
Shares Outstanding - Current
44.6M
Total Liabilities
1.02B
Total Volume MTD
N/A
Value
-1
Gain YTD
75.665
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com